← Back to Search

Tailored Care Coordination for Cardiovascular Disease

N/A

Waitlist Available

Led By Lisa M Kern, MD, MPH

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have cardiovascular disease or 1 or more cardiovascular risk factors

Medicare beneficiaries 65 years and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

Study Summary

This trial will test if assigning more care based on need is better for preventing hospital visits of high risk older adults.

Who is the study for?

This trial is for older adults aged 65+ who are part of the NewYork Quality Care organization, have heart disease or risk factors like high cholesterol or blood pressure, and had inconsistent outpatient care last year. It's not for those in hospice, long-term care facilities, or with dementia.Check my eligibility

What is being tested?

The study tests two ways to assign care coordinators to prevent hospital visits: one based on usual criteria after hospital discharge and another based on perceived need by healthcare providers.See study design

What are the potential side effects?

Since this trial involves care coordination rather than medication, there aren't typical drug side effects. However, participants may experience different levels of healthcare access which could impact their overall health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have heart disease or risk factors for heart disease.

Select...

I am 65 or older and receive Medicare benefits.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of emergency department visits or hospital admissions

Secondary outcome measures

Acceptability, as measured by change in the number of self-reported problems with care coordination

Appropriateness, as measured by the number of care coordination activities in each group, listed by type

Efficiency, as measured by the total number of care-coordinator hours used

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

The intervention group will assign care coordinators to individuals based on perceived need for assistance with care coordination. Perceived need will be measured through a proxy's responses to a previously validated telephone survey on perceptions of care coordination.

Group II: ControlActive Control1 Intervention

Usual care assigns patients to care coordinators in response to a discharge from a hospital or a direct referral from a physician.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED

399 Previous Clinical Trials

6,821,948 Total Patients Enrolled

3 Trials studying Atrial Fibrillation

5,821 Patients Enrolled for Atrial Fibrillation

Weill Medical College of Cornell UniversityLead Sponsor

1,055 Previous Clinical Trials

1,315,895 Total Patients Enrolled

6 Trials studying Atrial Fibrillation

1,494 Patients Enrolled for Atrial Fibrillation

Lisa M Kern, MD, MPHPrincipal InvestigatorWeill Medical College of Cornell University

3 Previous Clinical Trials

219,589 Total Patients Enrolled

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05820295 — N/A

Atrial Fibrillation Research Study Groups: Intervention, Control

Atrial Fibrillation Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05820295 — N/A

Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05820295 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available in this experiment for participants?

"This clinical trial is not actively recruiting, as evidenced by data posted on clinicaltrials.gov. Initially published on April 1st 2023 and last updated in the 7th of the same month, no new candidates are being sought out at this time. Nevertheless, there remain 5361 other medical studies currently accepting individuals for participation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination

2023. "Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05820295.

All > Afib > Atrial Fibrillation